To assess the ability of CAR-T cells to control tumor growth in vivo, we established a ccRCC orthotopic tumor bearing NSG-SGM3 mouse model where luciferized CAIX+ human ccRCC skrc-59 tumor cells are implanted under the murine kidney capsule [17]. The gene discussed is CA9; the disease is nonpapillary renal cell carcinoma.